Deficiency of adenosine deaminase 2 (DADA2) with bilateral renal subcapsular hematoma: a case report and literature review

被引:0
|
作者
Tuqan, Anas R. [1 ]
Barabrah, Anas M. [1 ]
Zaben, Basel A. [1 ]
Shehadeh, Mohammad Hakam [1 ]
Adas, Motaz M. [2 ]
机构
[1] Al Quds Univ, Fac Med, Jerusalem, Palestine
[2] Palestine Med Complex, Dept Internal Med, Ramallah, Palestine
来源
ANNALS OF MEDICINE AND SURGERY | 2024年 / 86卷 / 09期
关键词
adenosine deaminase 2; case report; DADA2; subcapsular hematoma;
D O I
10.1097/MS9.0000000000001812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and importance:Deficiency of adenosine deaminase 2 (DADA2) is a rare autosomal recessive genetic disorder caused by loss-of-function mutations in the adenosine deaminase 2 (ADA2) gene. This condition primarily manifests in pediatric cases before the age of 10 years, with sporadic cases reported in adults. ADA2 is a critical enzyme involved in macrophage differentiation and immune homeostasis. The clinical manifestations of DADA2 vary widely and can affect multiple organ systems. Our case uniquely highlights an infrequent DADA2 manifestation.Case presentation:An 18-year-old female presented with right flank pain, fever, and a history of joint pain, Raynaud's phenomenon, livedo-like rash, and chronic abdominal pain. Physical examination revealed subcapsular hematoma in the right kidney. Further evaluation showed positive serologic tests for rheumatoid factor and antinuclear antibody (ANA). Genetic testing confirmed DADA2 homozygosity. The patient was discharged on the appropriate medications.Clinical discussion:DADA2 is associated with vascular dysfunction and systemic vasculopathy. The clinical manifestations of DADA2 encompass a spectrum of organ involvement, including the skin, nervous system, gastrointestinal system, renal system, and the cardiovascular system. Early recognition and diagnosis are crucial for appropriate management.Conclusion:This case report highlights the diverse clinical presentations of ADA2 deficiency, specifically focusing on bilateral renal subcapsular hematoma. This finding emphasizes the importance of considering DADA2 as a differential diagnosis in patients presenting with unexplained renal manifestations. Increased awareness of the varied clinical presentations of DADA2 will contribute to earlier diagnosis, appropriate management, and improved outcomes in patients affected by this rare genetic disorder.
引用
收藏
页码:5476 / 5480
页数:5
相关论文
共 50 条
  • [31] Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment
    Isabelle Meyts
    Ivona Aksentijevich
    Journal of Clinical Immunology, 2018, 38 : 569 - 578
  • [32] Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)
    Lee, Pui Y.
    Kellner, Erinn S.
    Huang, Yuelong
    Furutani, Elissa
    Huang, Zhengping
    Bainter, Wayne
    Alosaimi, Mohammed F.
    Stafstrom, Kelsey
    Platt, Craig D.
    Stauber, Tali
    Raz, Somech
    Tirosh, Irit
    Weiss, Aaron
    Jordan, Michael B.
    Krupski, Christa
    Eleftheriou, Despina
    Brogan, Paul
    Sobh, Ali
    Baz, Zeina
    Lefranc, Gerard
    Irani, Carla
    Kilic, Sara S.
    El-Owaidy, Rasha
    Lokeshwar, M. R.
    Pimpale, Pallavi
    Khubchandani, Raju
    Chambers, Eugene P.
    Chou, Janet
    Geha, Raif S.
    Nigrovic, Peter A.
    Zhou, Qing
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (06) : 1664 - +
  • [33] Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)
    K Barron
    A Ombrello
    D Stone
    P Hoffmann
    I Aksentijevich
    Q Zhou
    A Jones
    D Kastner
    Pediatric Rheumatology, 13 (Suppl 1)
  • [34] Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance
    Schnappauf, Oskar
    Zhou, Qing
    Moura, Natalia Sampaio
    Ombrello, Amanda K.
    Michael, Drew G.
    Deuitch, Natalie
    Barron, Karyl
    Stone, Deborah L.
    Hoffmann, Patrycja
    Hershfield, Michael
    Applegate, Carolyn
    Bjornsson, Hans T.
    Beck, David B.
    Witmer, P. Dane
    Sobreira, Nara
    Wohler, Elizabeth
    Chiorini, John A.
    Dalgard, Clifton L.
    Kastner, Daniel L.
    Aksentijevich, Ivona
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (06) : 917 - 926
  • [35] Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance
    Oskar Schnappauf
    Qing Zhou
    Natalia Sampaio Moura
    Amanda K. Ombrello
    Drew G. Michael
    Natalie Deuitch
    Karyl Barron
    Deborah L. Stone
    Patrycja Hoffmann
    Michael Hershfield
    Carolyn Applegate
    Hans T. Bjornsson
    David B. Beck
    P. Dane Witmer
    Nara Sobreira
    Elizabeth Wohler
    John A. Chiorini
    The American Genome Center
    Clifton L. Dalgard
    NIH Intramural Sequencing Center
    Daniel L. Kastner
    Ivona Aksentijevich
    Journal of Clinical Immunology, 2020, 40 : 917 - 926
  • [36] Ischemic stroke as presentation of DADA2: Case report and literature review
    Motto, Cristina
    Teutonico, Federica
    Tovaglieri, Nicola
    Doneda, Paola
    Piano, Mariangela
    Vignoli, Aglaia
    De Giacomo, Costantino
    Agostoni, Elio Clemente
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 48 - 48
  • [37] Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2
    Carmona-Rivera, Carmelo
    Khaznadar, Sami S.
    Shwin, Kyawt W.
    Irizarry-Caro, Jorge A.
    O'Neil, Liam J.
    Liu, Yudong
    Jacobson, Kenneth A.
    Ombrello, Amanda K.
    Stone, Deborah L.
    Tsai, Wanxia L.
    Kastner, Daniel L.
    Aksentijevich, Ivona
    Kaplan, Mariana J.
    Grayson, Peter C.
    BLOOD, 2019, 134 (04) : 395 - 406
  • [38] Bilateral cataracts in a three-year-old with deficiency of adenosine deaminase 2 (DADA2), hyperferritinemia, and prolonged steroid use
    Abe-Ridgway, Kathryn
    Puente, Michael A.
    OPHTHALMIC GENETICS, 2025, 46 (01) : 74 - 78
  • [39] Identification of TNFa-Related Biomarkers in Patients and Carriers with Adenosine Deaminase 2 Deficiency (DADA2)
    Brittain, Alison
    Thomas, Megan Zavorka
    Brodeur, Kailey
    Esperanzate, Carl
    Driest, Kyla
    Buchbinder, David
    Chambers, Eugene
    Aksentijevich, Ivona
    Lee, Pui
    Abraham, Roshini
    CLINICAL IMMUNOLOGY, 2024, 262
  • [40] Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric study
    Kumar, Sathish
    Chugh, Akagri
    Kumar, Samantha Cheryl
    Punnen, Anu
    Bhat, Chandrika
    Patra, Pratap
    Viswanathan, Vijay
    Gupta, Aditya
    Aggarwal, Mukul
    Nayak, Amiya Ranjan
    Lingappa, Lokesh
    Sharma, Jyoti
    Gupta, Neerja
    Naranje, Priyanka
    Jana, Manisha
    Bagri, Narendra Kumar
    Hari, Pankaj
    Ramanan, Athimalaipet, V
    RHEUMATOLOGY, 2024,